Keywords: viropharma, wyeth, start, ph, ii, trial, hcv

ViroPharma and Wyeth start Ph II trial of HCV antiviral

Article | 30 October 2006

Print This

USA-based biopharmaceutical company ViroPharma says that it has begun patient dosing in a Phase II trial of HCV-796, an oral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in